Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines via Inhibition of NF-κB and STAT3 Pathways
-
- Puthdee Nattapong
- Department of Biochemistry, Faculty of Medicine, Khon Kaen University Cholangiocarcinoma Research Institute, Khon Kaen University
-
- Seubwai Wunchana
- Cholangiocarcinoma Research Institute, Khon Kaen University Department of Forensic Medicine, Faculty of Medicine, Khon Kaen University
-
- Vaeteewoottacharn Kulthida
- Department of Biochemistry, Faculty of Medicine, Khon Kaen University Cholangiocarcinoma Research Institute, Khon Kaen University
-
- Boonmars Thidarut
- Cholangiocarcinoma Research Institute, Khon Kaen University Department of Parasitology, Faculty of Medicine, Khon Kaen University
-
- Cha’on Ubon
- Department of Biochemistry, Faculty of Medicine, Khon Kaen University Cholangiocarcinoma Research Institute, Khon Kaen University
-
- Phoomak Chatchai
- Department of Biochemistry, Faculty of Medicine, Khon Kaen University Cholangiocarcinoma Research Institute, Khon Kaen University
-
- Wongkham Sopit
- Department of Biochemistry, Faculty of Medicine, Khon Kaen University Cholangiocarcinoma Research Institute, Khon Kaen University
書誌事項
- タイトル別名
-
- Berberine Induces Cell Cycle Arrest in Cholangiocarcinoma Cell Lines <i>via</i> Inhibition of NF-κB and STAT3 Pathways
この論文をさがす
説明
<p>Berberine is a natural compound found in several herbs. Anticancer activity of berberine was reported in several cancers, however, little is known regarding the effects of berberine against cholangiocarcinoma (CCA). In this study, the growth inhibitory effects of berberine on CCA cell lines and its molecular mechanisms were explored. Cell growth and cell cycle distribution were examined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry. The expression levels of cell cycle regulatory proteins were determined by Western blot analysis. Berberine significantly inhibited growth of CCA cell lines in a dose and time dependent fashion. The inhibition was largely attributed to cell cycle arrest at the G1 phase through the reduction of cyclin D1, and cyclin E. Moreover, berberine could reduce the expression and activation of signal transducers and activator of transcription 3 (STAT3) and probably nuclear factor-kappaB (NF-κB) via suppression of extracellular signal-regulated kinase (ERK) 1/2 action. These results highlight the potential of berberine to be a multi-target agent for CCA treatment.</p>
収録刊行物
-
- Biological & Pharmaceutical Bulletin
-
Biological & Pharmaceutical Bulletin 40 (6), 751-757, 2017
公益社団法人 日本薬学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204632025216
-
- NII論文ID
- 130005687992
-
- NII書誌ID
- AA10885497
-
- ISSN
- 13475215
- 09186158
-
- NDL書誌ID
- 028198131
-
- PubMed
- 28566619
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可